Experts In Pharmaceutical Development and Manufacturing Formulation Development Clinical Supplies Commercial Manufacturing Analytical Testing Dosage Packaging Trusted, End-To-End Pharmaceutical innovators, generics, and OTC owners rely on Halo Pharma to bring their small molecule therapeutics to market expeditiously, across a broad range of dosage forms and complexities, without compromising safety and quality.
Founded date: 1981
Investors 1
| Date | Name | Website |
| - | SK Capital... | skcapitalp... |
Mentions in press and media 5
| Date | Title | Description |
| 14.03.2024 | Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider | -The Noramco Group Addresses Critical Supply Chain Challenges, Offering Comprehensive Active Pharmaceutical Ingredients (API) and Drug Product Solutions- -Learn More from Company Leadership at DCAT Week 2024- WILMINGTON, Del.–(BUSINESS WIRE... |
| 14.05.2019 | Sekisui Diagnostics Invests $1.9M in Microbial Biopharma CDMO Business | Sekisui Diagnostics Enzyme business announces the completion of a new BioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a $1.9 million investment. This investment is part of a long-term investment str... |
| 26.08.2015 | Halo Pharmaceutical Makes Key Additions to Management Team | Whippany, New Jersey, August 26, 2015 – Halo Pharmaceutical, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to announce the appointments of Lee Karras as its Chief Executive Officer and Barry Lederm... |
| 06.01.2015 | SK Capital Makes Strategic Investment in Halo Pharmaceutical | NEW YORK, January 6, 2015 – NEW YORK — (BUSINESS WIRE) — SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced today that it has completed a controlli... |
| - | Halo Pharmaceutical | “Halo Pharma is a full-service pharma/biotech CDMO for outsourcing end-to-end drug product development and commercial manufacturing, including complex formulations” |